Steven A. Skinner, M.D.
Senior Clinical Geneticist
Director, Greenwood Genetic Center
Contact: 864-941-8100 or email@example.com
Who is Dr. Skinner?
Dr. Skinner obtained his undergraduate degree from Wofford College and his M.D. from MUSC in Charleston, S.C. After completing his pediatric residency at Richland Memorial Hospital in Columbia, S.C, he practiced general pediatrics in Georgetown, S.C. Dr. Skinner completed a residency in Clinical Genetics at the Greenwood Genetic Center (GGC) in 1989. He is Board Certified in both Pediatrics and Clinical Genetics. He is a fellow in both the American Academy of Pediatrics and the American College of Medical Genetics.
Dr. Skinner has been actively involved with public health initiatives at S.C. DDSN and S.C. DHEC. At the Greenwood Genetic Center, his clinical focus has been on intellectual disabilities and autism. He has been actively involved with NIH funded Natural History Studies for Rett Syndrome, Angelman Syndrome and, more recently, CDKL5 syndrome, FOXG1 syndrome and MECP2 Duplication syndrome. In addition, he has been actively involved with clinical trials for Angelman Syndrome, Rett Syndrome and Fragile X Syndrome.
For the past 6 years, Dr. Skinner has worked closely with the administration and faculty at Clemson University (CU) to develop the Clemson University Center for Human Genetics. This activity has included working with CU administration to obtain funding from Self Regional Healthcare to support collaborative research between CU and GGC faculty. He has served on the search committee for the Self Family Foundation Endowed Chair at the CU Center for Human Genetics. He has served on the review team for the collaborative research grants funded by Self Regional Healthcare.For more information, see his Curriculum Vitae.
How Dr. Skinner’s research is transforming health care
Dr. Skinner has been actively involved in NIH funded Natural History Studies of Rett Syndrome and Angelman Syndrome. These have been multi-institutional, longitudinal studies over the past 12 years and are still continuing. These studies have been instrumental in the development and design of current clinical trials for these conditions.
Dr. Skinner has also been actively involved in industry sponsored clinical trials for Rett syndrome, Angelman syndrome and Fragile X syndrome.
Dr. Skinner is also focused on developing collaborative approaches with public and private entities to combine clinical services, basic science research and translational research to better meet the needs of patients with rare and/or chronic conditions.
News and Media Related to Dr. Skinner’s research
- Fragile X trial article in Index Journal
- A Rett Natural History study PR
Key Health Research Interest Areas
Rett syndrome, Angelman syndrome, Autism, Fragile X syndrome, Translational research, Clinical trials